Percutaneous Navigation Under Local Anesthesia for Computed Tomography-Guided Microwave Ablation of Malignant Liver Lesions Located in the Hepatic Dome

Overview

Journal Medicina (Kaunas)

Publisher MDPI

Specialty General Medicine

Date 2021 Oct 23

PMID 34684093

Citations 3

Authors

Dimitrios K Filippiadis

Georgios Velonakis

Argyro Mazioti

Athanasios Tsochatzis

Thomas Vrachliotis

Alexis Kelekis

Nikolaos Kelekis

Affiliations

Soon will be listed here.

Abstract

The aim of the present study was to report the safety and efficacy of percutaneous navigation under local anesthesia for computed tomography-guided microwave ablation of malignant liver lesions located in the hepatic dome. Patients with primary and secondary malignant liver lesions located in the hepatic dome who underwent percutaneous computed tomography-guided microwave ablation using a computer-assisted navigation system under local anesthesia were prospectively evaluated. The primary objective was technical success. The sample consisted of 10 participants (16 lesions) with a mean age of 60.60 years (SD = 9.25 years) and a mean size of 20.37 ± 7.29 cm, and the mean follow-up time was 3.4 months (SD = 1.41) months. Primary technical success was 93.75%. Tumor remnant was noticed at one month follow-up in a single metastatic lesion, which was re-treated with an ablation session, and no tumor remnant was depicted in the subsequent imaging follow-up (secondary technical success 100%). Grade I self-limited complications (according to the CIRSE classification system) included small pleural effusion ( = 1) and minor bleeding post antenna removal ( = 1) requiring nothing but observation. the findings of the present study indicate that percutaneous navigation under local anesthesia is a safe and efficacious approach for computed tomography-guided microwave ablation of malignant liver lesions located in the hepatic dome. Large randomized controlled studies are warranted to observe treatment effectiveness and compare the results with those of other options.

Citing Articles

Cryoprobe Placement Using Electromagnetic Navigation System (IMACTIS® CT-Navigation™) for Cryoablation Treatment of Upper Kidney Pole Lesions and Adrenal Metastases: Experience from a Single-Center, 4-Year Study.

Michailidis A, Kosmoliaptsis P, Dimou G, Mingou G, Zlika S, Giankoulof C Diagnostics (Basel). 2024; 14(17).

PMID: 39272747 PMC: 11393891. DOI: 10.3390/diagnostics14171963.

Navigation and Robotics in Interventional Oncology: Current Status and Future Roadmap.

Charalampopoulos G, Bale R, Filippiadis D, Odisio B, Wood B, Solbiati L Diagnostics (Basel). 2024; 14(1).

PMID: 38201407 PMC: 10795729. DOI: 10.3390/diagnostics14010098.

Role of Percutaneous Ablation in the Management of Intrahepatic Cholangiocarcinoma.

Charalampopoulos G, Iezzi R, Tsitskari M, Mazioti A, Papakonstantinou O, Kelekis A Medicina (Kaunas). 2023; 59(7).

PMID: 37511998 PMC: 10386331. DOI: 10.3390/medicina59071186.

References

Tinguely P, Frehner L, Lachenmayer A, Banz V, Weber S, Candinas D . Stereotactic Image-Guided Microwave Ablation for Malignant Liver Tumors-A Multivariable Accuracy and Efficacy Analysis. Front Oncol. 2020; 10:842. PMC: 7298123. DOI: 10.3389/fonc.2020.00842. View

Cornelis F, Monard E, Moulin M, Vignaud E, Laveissiere F, Ben Ammar M . Sedation and analgesia in interventional radiology: Where do we stand, where are we heading and why does it matter?. Diagn Interv Imaging. 2019; 100(12):753-762. DOI: 10.1016/j.diii.2019.10.002. View

Filippiadis D, Spiliopoulos S, Konstantos C, Reppas L, Kelekis A, Brountzos E . Computed tomography-guided percutaneous microwave ablation of hepatocellular carcinoma in challenging locations: safety and efficacy of high-power microwave platforms. Int J Hyperthermia. 2017; 34(6):863-869. DOI: 10.1080/02656736.2017.1370728. View

Perrodin S, Lachenmayer A, Maurer M, Kim-Fuchs C, Candinas D, Banz V . Percutaneous stereotactic image-guided microwave ablation for malignant liver lesions. Sci Rep. 2019; 9(1):13836. PMC: 6761186. DOI: 10.1038/s41598-019-50159-3. View

Filippiadis D, Binkert C, Pellerin O, Hoffmann R, Krajina A, Pereira P . Cirse Quality Assurance Document and Standards for Classification of Complications: The Cirse Classification System. Cardiovasc Intervent Radiol. 2017; 40(8):1141-1146. DOI: 10.1007/s00270-017-1703-4. View

Rouchy R, Moreau-Gaudry A, Chipon E, Aubry S, Pazart L, Lapuyade B . Evaluation of the clinical benefit of an electromagnetic navigation system for CT-guided interventional radiology procedures in the thoraco-abdominal region compared with conventional CT guidance (CTNAV II): study protocol for a randomised.... Trials. 2017; 18(1):306. PMC: 5501074. DOI: 10.1186/s13063-017-2049-6. View

Filippiadis D, Velonakis G, Kelekis A, Sofocleous C . The Role of Percutaneous Ablation in the Management of Colorectal Cancer Liver Metastatic Disease. Diagnostics (Basel). 2021; 11(2). PMC: 7918461. DOI: 10.3390/diagnostics11020308. View

An T, Arellano R . Comparison of Safety and Efficacy of Percutaneous Microwave Ablation of Central Versus Peripheral Renal Cell Carcinoma. Cardiovasc Intervent Radiol. 2020; 44(2):281-288. DOI: 10.1007/s00270-020-02674-4. View

Schullian P, Johnston E, Putzer D, Eberle G, Laimer G, Bale R . Stereotactic radiofrequency ablation of subcardiac hepatocellular carcinoma: a case-control study. Int J Hyperthermia. 2019; 36(1):876-885. DOI: 10.1080/02656736.2019.1648886. View

10.

Van Cutsem E, Cervantes A, Adam R, Sobrero A, van Krieken J, Aderka D . ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016; 27(8):1386-422. DOI: 10.1093/annonc/mdw235. View

11.

Crocetti L, De Baere T, Pereira P, Tarantino F . CIRSE Standards of Practice on Thermal Ablation of Liver Tumours. Cardiovasc Intervent Radiol. 2020; 43(7):951-962. DOI: 10.1007/s00270-020-02471-z. View

12.

Mulier S, Ni Y, Jamart J, Ruers T, Marchal G, Michel L . Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg. 2005; 242(2):158-71. PMC: 1357720. DOI: 10.1097/01.sla.0000171032.99149.fe. View

13.

Schaible J, Lurken L, Wiggermann P, Verloh N, Einspieler I, Zeman F . Primary efficacy of percutaneous microwave ablation of malignant liver tumors: comparison of stereotactic and conventional manual guidance. Sci Rep. 2020; 10(1):18835. PMC: 7608621. DOI: 10.1038/s41598-020-75925-6. View

14.

Schullian P, Johnston E, Laimer G, Putzer D, Eberle G, Scharll Y . Stereotactic Radiofrequency Ablation of Breast Cancer Liver Metastases: Short- and Long-Term Results with Predicting Factors for Survival. Cardiovasc Intervent Radiol. 2021; 44(8):1184-1193. PMC: 8249280. DOI: 10.1007/s00270-021-02820-6. View

15.

Lachenmayer A, Tinguely P, Maurer M, Frehner L, Knopfli M, Peterhans M . Stereotactic image-guided microwave ablation of hepatocellular carcinoma using a computer-assisted navigation system. Liver Int. 2019; 39(10):1975-1985. DOI: 10.1111/liv.14187. View

16.

Ahmed M, Solbiati L, Brace C, Breen D, Callstrom M, Charboneau J . Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. Radiology. 2014; 273(1):241-60. PMC: 4263618. DOI: 10.1148/radiol.14132958. View

17.

Howenstein M, Sato K . Complications of radiofrequency ablation of hepatic, pulmonary, and renal neoplasms. Semin Intervent Radiol. 2012; 27(3):285-95. PMC: 3324191. DOI: 10.1055/s-0030-1261787. View